Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN   US09061G1013

Delayed Quote. Delayed Nasdaq - 11/26 04:00:00 pm
89.38 USD   -0.08%
3d agoDJU.S. Stocks Close Higher
3d ago S&P 500 ticks up to record on central bank bets
3d agoDJU.S. Stocks Pare Gains
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/20/2014 11/21/2014 11/24/2014 11/25/2014 11/26/2014 Date
84.43(c) 85.83(c) 87.94(c) 89.45(c) 89.38(c) Last
690 654 847 435 2 935 302 1 957 827 917 939 Volume
-0.76% +1.66% +2.46% +1.72% -0.08% Change
More quotes
Company
BioMarin Pharmaceutical, Inc. develops and commercializes innovative pharmaceuticals for serious diseases and medical conditions.The company operates its business through one segment, the biopharmaceutical development and commercialization segment.Its company's product portfolio is comprised of... 
Sector
Pharmaceuticals
Calendar
12/02 | 10:30amPresentation
Surperformance© rating of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More about the company
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 708 M
EBIT 2014 -121 M
Net income 2014 -153 M
Debt 2014 280 M
Yield 2014 -
Sales 2015 872 M
EBIT 2015 -174 M
Net income 2015 -227 M
Debt 2015 287 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 19,0x
EV / Sales 2015 15,4x
Capitalization 13 180 M
More Financials
Latest news on BIOMARIN PHARMACEUTICAL IN
1d ago BIOMARIN PHARMACEUTICAL : Entry into a Material Definitive Agreement, Financial ..
3d agoDJU.S. Stocks Close Higher
3d ago S&P 500 ticks up to record on central bank bets
3d ago BIOMARIN PHARMACEUTICAL : Other Events, Financial Statements and Exhibits (form ..
3d agoDJU.S. Stocks Pare Gains
3d ago BioMarin to buy Prosensa in $840 million deal
3d ago BIOMARIN PHARMACEUTICAL : Pharma offers about $680M for Prosensa
3d ago BioMarin and Prosensa Holding N.V. Reach Agreement on Intended Public Offer f..
11/19 BIOMARIN PHARMACEUTICAL : to Attend Upcoming Investor Conferences
11/12 BIOMARIN PHARMACEUTICAL : Researchers Submit Patent Application, "Processes of S..
11/04 BIOMARIN PHARMACEUTICAL : Jean-Jacques Bienaime, CEO of BioMarin, to Present at ..
10/23 BIOMARIN PHARMACEUTICAL : beats 3Q profit forecasts
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF